A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate. The recommendations at the CDSCO have been sent to the Drugs Controller General of India for approval.

Source: Nod to Serum Institute for trials of Oxford vaccine